Telehealth ads: LegitScript, Google warnings, and bans

Short answer: Telehealth ad approval on Google is not one review. For prescription services, the business may need third-party certification and Google authorization. The ad and landing page must still satisfy content rules. A clean creative cannot repair a missing certification, and certification cannot rescue a misleading claim.

That is why teams can rewrite an ad repeatedly and see the same rejection. They are solving the creative while the failing layer is the business, account, destination, or measurement setup.

What does certification cost?

LegitScript's current pricing page lists the application and annual fees per website. The application fee is nonrefundable. Expedited processing starts review within two business days; it does not promise completion in two days. The deeper breakdown and application checklist live in LegitScript certification cost and timeline.

Do you need LegitScript certification to run telehealth ads?

For ads promoting prescription services in the United States, Google applies certification and authorization requirements. Google allows certified telemedicine providers to promote prescription-drug services under location-specific limits, and Google requires its own healthcare certification application.

The category and the destination matter. General education or brand advertising may sit outside a prescription-service authorization requirement on a platform, while a landing page that facilitates prescribing can put the advertiser back inside it. Policies also vary by country and change over time. Check the exact target locations and current platform text before launch.

Certification gets the business into review. It confirms the business cleared a defined process. Each campaign's claim, landing page, targeting, and measurement still gets judged on its own.

How long does approval take?

LegitScript does not promise a standard review time. Its certification FAQ says every application is different, so it is unable to provide an estimated timeline. Review times vary with application complexity, the completeness of the submission, how quickly the applicant responds to requests, and current application volume. Expedited processing adds $2,500 and starts review within two business days. LegitScript says it does not shorten the compliance review itself. You pay to start sooner.

Google authorization follows its own process after any required third-party certification. That makes a firm campaign launch date risky until every required approval is visible in the account.

Google's application instructions include a detail that catches agency-run accounts: submit at the child account level, not the manager account level. Google also tells advertisers to review the location-specific requirements for every market they target. A company licensed and certified for one footprint should not assume the same permission follows it into another.

Why are telehealth ads rejected after certification?

Certification clears the business layer. Creative, destination, and account review remain.

The content problems are familiar: an ad implies knowledge of the viewer's health condition, promises an outcome or timeline, uses before-and-after framing, or lets an image make a claim the copy avoids. The destination can fail even when the ad is clean. Google's prescription-drug-services policy says it looks at the ad, site, app, products, and services, and that it errs on the side of caution for destinations that appear to facilitate online prescribing, dispensing, or sale of medicines.

Review the ad, landing page, intake path, and claim support as one unit. Why health ads get rejected owns the creative rewrite. The five evidence-backed compliance patterns own the regulator view.

How do Google telehealth ad accounts get suspended?

Google documents two different enforcement paths.

For its prescription-drug-services policy, Google says violations do not lead to immediate suspension without prior warning and that a warning will arrive at least seven days before suspension. That is the ordinary correction path: a policy decision, time to fix, and an appeal if the advertiser believes Google made an error.

Unauthorized-pharmacy violations sit in Google's egregious tier. The policy prohibits offering prescription drugs without a prescription and targeting locations where the advertiser is not licensed. Google says accounts can be suspended upon detection without prior warning and that reinstatement happens only in compelling circumstances.

Do not collapse these into one generic "healthcare suspension" rule. The service, certification, license footprint, destination, and conduct determine which path applies. A rejection is not the same event as an egregious suspension.

Should you route around the rules?

Fresh accounts, borrowed agency accounts, or a "wellness" page that hides the prescription funnel one click deeper do not change what the business offers. Google says it may review the ad, website, accounts, and third-party sources when evaluating an egregious violation. A structure built to hide the service hands that review more evidence. Use the account that belongs to the advertiser, certify the business, disclose what the service does, and appeal a decision with complete documentation when Google gets it wrong.

What should happen before spend begins?

Treat certification as an outside dependency and start it first. Standard review has no promised completion date, and platform authorization remains separate. A media date should not depend on a queue you cannot see.

The other workstreams do not need a universal order. Landing pages, claim support, measurement, creative, and the patient handoff can move in parallel as long as one accountable owner reviews the final system together. The order should follow the company's real bottleneck.

Before budget moves, run the campaign through the paid-ads preflight. It checks the offer, claim, destination, measurement plan, and handoff in one pass. Whether the auction is economically justified is a different question, covered in what it costs to acquire a telehealth patient.

FAQ

How long does LegitScript certification take for a telehealth company?

LegitScript says every application is different and it is unable to provide an estimated certification timeline. Expedited processing costs $2,500 and starts review within two business days, but does not promise completion in that window.

Can you run telehealth ads without LegitScript certification?

It depends on what the ad and destination promote and the target location. Google requires certification for prescription-service advertising in allowed markets. Check the current location-specific policy for the exact campaign.

Why was my telehealth ad rejected for personal attributes?

Health ads can violate platform rules when they imply knowledge of the viewer's condition. Reframe around the service, topic, or eligible population instead of diagnosing the person reading the ad.

Does an ad account suspension affect LegitScript pricing?

LegitScript lists a probationary certification tier at $3,995 a year instead of $2,150, with more in-depth and frequent monitoring. LegitScript decides eligibility and discusses it with the applicant before certification.

Sources checked August 22, 2026 (LegitScript timeline and Google warning wording rechecked October 3, 2026): LegitScript healthcare certification and pricing, LegitScript certification FAQ, Google Ads prescription drug services policy, and Google Ads unauthorized pharmacies policy. This page discusses marketing operations, not law. Use legal and regulatory review for a specific campaign.